Table 3:

Association between predictors and occurrence of serious adverse events

Predictor*Outcome; no. (%) or mean ± SDp valueκ value
Serious adverse event
n = 147
No serious adverse event
n = 3883
Demographic
Age, yr71.6 ± 16.752.9 ± 23.0< 0.001
Female sex63 (42.9)2175 (56.0)0.002
Medical history
Vascular disease (n = 147; 3876)16 (10.9)238 (6.1)0.020.85
Heart disease§ (n = 138; 3639)83 (60.1)748 (20.6)< 0.0010.95
Event details
Predisposition to vasovagal syncope (n = 147; 3820)19 (12.9)1642 (43.0)< 0.0010.48
Presence of prodrome** (n = 144; 3817)82 (56.9)2903 (76.1)< 0.0010.57
Vital sign in emergency department
Triage systolic BP (n = 142; 3769)133.3 ± 33.0125.3 ± 21.40.005
Highest systolic BP (n = 147; 3853)149.1 ± 29.5137.1 ± 22.1< 0.001
Lowest diastolic BP (n = 146; 3851)61.6 ± 17.365.3 ± 12.80.01
Highest diastolic BP (n = 147; 3850)83.6 ± 17.680.4 ± 13.60.03
Highest heart rate (n = 147; 3851)87.2 ± 19.784 ± 16.60.05
Triage respiratory rate (n = 119; 3099)18.0 ± 3.817.2 ± 2.60.04
Laboratory value
Elevated troponin (> 99th percentile of normal population)37 (25.2)132 (3.4)< 0.001
Hematocrit (n = 145; 3225)0.38 ± 0.060.40 ± 0.05< 0.001
Serum urea, mmol/L (n = 134; 2939)8.8 ± 6.86.4 ± 4.4< 0.001
Serum creatinine, μmol/L (n = 145; 3157)109.5 ± 68.288.4 ± 66.0< 0.001
ECG evidence (n = 143; 3691)
Left bundle branch block15 (11.4)85 (2.3)< 0.0010.88
Left ventricular hypertrophy13 (9.9)199 (5.5)0.030.83
QRS duration, ms111.1 ± 31.793.0 ± 17.6< 0.001
QRS axis, degrees16.0 ± 60.435.6 ± 42.3< 0.001
Corrected QT interval, ms463.6 ± 43.3431.7 ± 30.7< 0.001
Diagnosis in emergency department
Vasovagal syncope19 (13.0)2165 (55.8)< 0.0010.60
Cardiac syncope51 (34.9)194 (5.0)< 0.0010.60
Categorization of continuous predictors
Age > 75 yr72 (49.0)871 (22.4)< 0.001
Any systolic BP < 90 or > 180 mm Hg†† (n = 147; 3871)46 (31.3)446 (11.5)< 0.001
Lowest diastolic BP < 50 mm Hg30 (20.6)348 (9.0)< 0.001
Highest diastolic BP > 110 mm Hg12 (8.2)90 (2.3)< 0.001
Highest heart rate > 110 beats/min18 (12.2)244 (6.3)0.004
Triage respiratory rate > 20 breaths/min12 (10.1)109 (3.5)< 0.001
Hematocrit < 0.313 (9.0)113 (3.5)< 0.001
Urea > 12 mmol/L21 (15.7)164 (5.6)< 0.001
Creatinine > 150 μmol/L17 (11.7)170 (5.4)0.001
QRS duration > 130 ms42 (31.6)186 (5.1)< 0.001
Abnormal QRS axis (< −30° or > 110°)43 (32.3)307 (8.3)< 0.001
Corrected QT interval > 480 ms51 (38.4)236 (6.4)< 0.001
  • Note: BP = blood pressure, ECG = electrocardiogram.

  • * Numbers within brackets indicate the number of patients in each group for whom data were available for the variable. Where numbers are not reported, the data were available for all of the patients.

  • Interobserver assessments were conducted for data from 190 (4.7%) of the 4030 patients.

  • Includes transient ischemic attack, cerebrovascular accident and peripheral vascular disease.

  • § Includes coronary or valvular heart disease, cardiomyopathy, congestive heart failure and non-sinus rhythm (ECG evidence during index visit or documented history of ventricular or atrial arrhythmias, or device implantation).

  • Triggered by being in a warm crowded place, prolonged standing, fear, emotion or pain.

  • ** Dizziness, light-headedness, vision changes, nausea or vomiting.

  • †† Includes BP values from triage until disposition from emergency department.